Mock FDA Inspection by Former FDA Investigators
A mock FDA inspection conducted by former FDA investigators who understand how regulatory inspections are performed in practice. We provide independent assessment of inspection readiness for medical device, drug, and combination product manufacturers through remote or onsite support. Our approach helps organizations identify compliance gaps, evaluate quality systems, review documentation, and strengthen inspection response before the FDA arrives. This service is designed for companies that want practical feedback based on real regulatory experience, not generic consulting language.
This service provides an independent evaluation of inspection readiness for medical device, pharmaceutical, and combination product manufacturers. The mock inspection simulates the structure and expectations of an actual FDA inspection, including review of quality systems, manufacturing records, procedures, and supporting documentation. Organizations receive practical feedback on potential compliance gaps, documentation weaknesses, and areas that may draw regulatory attention during an inspection. The objective is to help companies strengthen their inspection readiness, improve internal processes, and ensure personnel understand how to respond to investigator requests and questions. Mock FDA inspections may be conducted remotely or onsite, depending on the organization’s needs, and are designed to provide realistic preparation before an actual regulatory inspection occurs.
Prepare for FDA with People Who Understand FDA Inspections
Prepare for FDA inspections with professionals who have firsthand experience conducting regulatory inspections. Our team includes former FDA investigators who understand how inspections are planned, executed, and documented. This experience allows us to evaluate your organization from the perspective of an investigator, focusing on areas that typically receive regulatory scrutiny during inspections. We assess quality systems, manufacturing controls, procedures, records, and overall compliance with applicable regulatory requirements. The goal is to identify potential gaps before FDA arrives and provide practical recommendations that strengthen inspection readiness. Companies benefit from realistic preparation, clear expectations, and insight into how investigators review documentation, interview personnel, and assess compliance during an inspection. This approach helps organizations improve internal preparedness and respond confidently during an actual FDA inspection.
Medical Device, Drug, and Combination Product Expertise
Medical Device Regulatory Review
For medical device manufacturers, the assessment focuses on the implementation of quality systems, including design controls, production and process controls, complaint handling, corrective and preventive action, and documentation practices required under applicable regulatory requirements.
Pharmaceutical GMP Evaluation
For pharmaceutical manufacturers, the review may include current good manufacturing practice requirements, manufacturing controls, laboratory practices, batch records, and quality oversight systems used to maintain product quality and regulatory compliance.
Combination Product Regulatory Framework
Combination product manufacturers often operate under both device and drug regulatory expectations. The mock inspection may evaluate how organizations manage overlapping regulatory requirements, quality systems integration, and compliance with applicable combination product regulations.
What Our Mock FDA Inspection Covers
A mock FDA inspection is designed to simulate the scope and approach of an actual regulatory inspection. The objective is to evaluate inspection readiness by reviewing quality systems, procedures, records, and operational practices that FDA investigators typically examine during an inspection. This process helps organizations identify potential compliance gaps and areas that may require corrective action before a regulatory inspection occurs.
Quality System and Compliance Review
The mock inspection includes evaluation of quality system implementation, written procedures, and supporting documentation. This may involve review of quality manuals, standard operating procedures, training records, internal audits, management review activities, and other key elements that demonstrate how the quality system is implemented and maintained.
Manufacturing and Process Controls
Manufacturing operations and process controls are reviewed to assess whether procedures are followed and records support regulatory compliance. This may include examination of production processes, equipment controls, process validation documentation, and production records where applicable.
Documentation and Record Examination
Regulatory inspections often focus heavily on documentation. The mock inspection reviews selected records such as batch records, device history records, change control documentation, CAPA records, complaint files, and other quality system documentation to determine whether records are complete, accurate, and consistent.
Personnel Interview Preparation
Personnel may be asked questions similar to those asked during an FDA inspection. This helps employees understand how to respond clearly and accurately to investigator questions and improves organizational readiness for an actual inspection.
Who This Service Is For
This service is designed for organizations operating in FDA-regulated industries that want to evaluate their readiness before a regulatory inspection occurs. Mock FDA inspections are particularly useful for companies preparing for an upcoming inspection, organizations that have not been inspected for several years, or firms that want an independent assessment of their compliance systems.
Medical device manufacturers, pharmaceutical companies, and combination product firms may benefit from this service when preparing for FDA inspections or strengthening internal quality systems. The mock inspection can also support companies implementing new regulatory requirements, expanding manufacturing operations, or preparing new personnel for inspection responsibilities.
Organizations that want a realistic evaluation of inspection readiness often seek independent review from professionals familiar with FDA inspection practices. By identifying potential gaps and areas for improvement early, companies can strengthen compliance programs and improve preparedness before an actual FDA inspection takes place.
Remote or Onsite Mock FDA Inspection
Mock FDA inspections may be conducted either remotely or onsite depending on the needs of the organization. A remote mock inspection allows companies to submit documentation electronically for review while participating in virtual meetings to simulate investigator interactions and document requests. This approach provides flexibility and allows organizations to evaluate inspection readiness without travel or scheduling constraints.
An onsite mock inspection provides a more traditional inspection simulation where the inspection team visits the facility and evaluates operations in person. This may include review of documentation, walkthrough of manufacturing areas, and direct interaction with personnel responsible for quality, regulatory, and manufacturing functions.
Both approaches are designed to simulate the structure and expectations of an FDA inspection. The objective is to identify potential compliance gaps, assess documentation and processes, and prepare the organization for how an actual inspection may unfold.
Why Former FDA Investigators Matter
Mock FDA inspections are most effective when conducted by individuals who understand how regulatory inspections are performed in practice. Former FDA investigators have firsthand experience conducting inspections, reviewing documentation, interviewing personnel, and evaluating compliance with regulatory requirements. This experience allows them to approach the mock inspection from the same perspective used during an actual FDA inspection.
During the mock inspection, former investigators focus on areas that commonly receive regulatory attention, including quality system implementation, documentation practices, manufacturing controls, and overall compliance with applicable regulations. Their experience helps organizations understand how investigators evaluate records, interpret procedures, and identify potential compliance concerns.
By simulating the inspection process based on real regulatory experience, companies gain practical insight into how an FDA inspection may unfold and where improvements may be needed to strengthen inspection readiness.
Schedule a Mock FDA Inspection
Organizations interested in evaluating their inspection readiness may schedule a mock FDA inspection based on availability and project scope. The service may be conducted remotely or onsite, depending on the needs of the organization and the complexity of the quality system being reviewed.
Before the mock inspection begins, the scope of the review is discussed to determine the applicable regulatory framework, product type, and key quality system areas to be evaluated. This allows the mock inspection to focus on relevant regulatory requirements and operational practices.
Companies seeking mock FDA inspection services may submit an inquiry through the contact form to discuss project timing, scope, and inspection format. Early preparation allows organizations to address potential compliance gaps and improve internal readiness before an actual FDA inspection occurs.